glp-1 drug novo nordisk Novo, Lilly buoyed by fast-growing sales Novo Nordisk hikes full-year forecast
Description
History of pancreatitis : GLP-1 agonists may increase the risk of pancreatitis in some individuals
Symptoms have been reported from two days to five months after initiating DPP-4 inhibitors
Liu L., Chen J., Wang L., Chen C., and Chen L., Association Between Different GLP1 Receptor Agonists and Gastrointestinal Adverse Reactions: A RealWorld Disproportionality Study Based on FDA Adverse Event Reporting System Database, Frontiers in Endocrinology 13 (2022): 1043789
doi: 10.1038/nature22394 41 MichelMCWielandTTsujimotoG
